Hint mode is switched on Switch off

Cardiff Oncology, ordinary share
CRDF, US14147L1089

Add a stock to WL
Choose all Reset all
Cardiff Oncology, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Cardiff Oncology Inc operates as a biotech company. The Company develops therapies and treatments for solid tumor and hematologic cancers. Cardiff Oncology serves customers in the States of California.
  • Issuer
  • Full borrower / issuer name
    Cardiff Oncology Inc (formerly Trovagene Inc)
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CRDF
  • Placement
    30.09.2020
  • Lock up period
    180
  • Number of papers
    6,500,000
  • Volume of raised funds
    87.75 mln USD
  • Placement share
    21.54%
  • Final placement price
    13.5 USD
  • Price change since placement date
    -88.89%
  • By capitalization
    407.38 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CRDF
  • Placement
    11.12.2024
  • Lock up period
    180
  • Number of papers
    15,384,619
  • Volume of raised funds
    40 mln USD
  • Placement share
    23.13%
  • Final placement price
    2.6 USD
  • Price change since placement date
    -42.31%
  • By capitalization
    172.96 mln USD

IFRS/US GAAP reports

2025
I q eng
II q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide

Related Stock indices

Indicators

News

03/06/2026 Cardiff Oncology: Regulation Fd Disclosure, Financial Statements And Exhibits
27/05/2026 Cardiff Oncology: Entry Into A Material Definitive Agreement
19/05/2026 Cardiff Oncology: Other Events
29/07/2025 Cardiff Oncology: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
26/06/2025 Cardiff Oncology: Submission Of Matters To A Vote Of Security Holders
All organization news

Holders

Industry Leaders

Registration is required to get access.